A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

Clinical Trial Description

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

The secondary objectives of this study are to evaluate the clinical effect of A-101 when applied to all treated warts (Target Warts plus Non-Target Warts), duration of response in all treated warts (Target Warts plus Non-Target Warts), and Safety of A-101. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03210337
Study type	Interventional
Source	Aclaris Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	August 1, 2017
Completion date	March 16, 2018

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT01796795` - Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients	Phase 2
Completed	`NCT03687372` - Study of A-101 Topical Solution for the Treatment of Common Warts	Phase 3
Completed	`NCT03691831` - A Study of A-101 Topical Solution for the Treatment of Common Warts	Phase 3
Completed	`NCT00328991` - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts	N/A
Completed	`NCT05115669` - Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts	N/A
Completed	`NCT03487549` - Cantharidin and Occlusion in Verruca Epithelium	Phase 2
Not yet recruiting	`NCT04288817` - Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts	Phase 3
Active, not recruiting	`NCT05896215` - OM202JP Clinical Study of KNP2002	Phase 2
Completed	`NCT03278028` - A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts	Phase 2
Completed	`NCT03812510` - Safety Study of A-101 Topical Solution for the Treatment of Common Warts	Phase 3
Recruiting	`NCT05799157` - Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts	Phase 2
Recruiting	`NCT06214559` - Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.	N/A
Recruiting	`NCT03977753` - Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts	Phase 4
Completed	`NCT03183765` - Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts	Phase 4